259 related articles for article (PubMed ID: 2797631)
21. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
Terres W; Schuster O; Kupper W; Bleifeld W
Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
[TBL] [Abstract][Full Text] [Related]
22. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
[TBL] [Abstract][Full Text] [Related]
23. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
FitzGerald GA; Lupinetti M; Charman SA; Charman WN
J Pharmacol Exp Ther; 1991 Dec; 259(3):1043-9. PubMed ID: 1762060
[TBL] [Abstract][Full Text] [Related]
24. Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation.
Lev EI; Solodky A; Harel N; Mager A; Brosh D; Assali A; Roller M; Battler A; Kleiman NS; Kornowski R
J Am Coll Cardiol; 2010 Jan; 55(2):114-21. PubMed ID: 20117379
[TBL] [Abstract][Full Text] [Related]
25. A prostacyclin-sparing effect of indobufen vs. aspirin.
De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
[TBL] [Abstract][Full Text] [Related]
26. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
[TBL] [Abstract][Full Text] [Related]
27. A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension.
Louden KA; Broughton Pipkin F; Symonds EM; Tuohy P; O'Callaghan C; Heptinstall S; Fox S; Mitchell JR
Br J Obstet Gynaecol; 1992 May; 99(5):371-6. PubMed ID: 1622907
[TBL] [Abstract][Full Text] [Related]
28. [Low-dose aspirin preventing pregnancy induced hypertension].
Cheng WW; Zhang ZJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):342-5, 387. PubMed ID: 1804603
[TBL] [Abstract][Full Text] [Related]
29. Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo.
Hampton KK; Cerletti C; Loizou LA; Bucchi F; Donati MB; Davies JA; de Gaetano G; Prentice CR
Thromb Haemost; 1990 Aug; 64(1):17-20. PubMed ID: 2073296
[TBL] [Abstract][Full Text] [Related]
30. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
Pedersen AK; FitzGerald GA
N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
[TBL] [Abstract][Full Text] [Related]
31. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
[TBL] [Abstract][Full Text] [Related]
32. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
Hauth J; Sibai B; Caritis S; VanDorsten P; Lindheimer M; Klebanoff M; MacPherson C; Landon M; Paul R; Miodovnik M; Meis P; Dombrowski M; Thurnau G; Walsh S; McNellis D; Roberts JM
Am J Obstet Gynecol; 1998 Nov; 179(5):1193-9. PubMed ID: 9822499
[TBL] [Abstract][Full Text] [Related]
33. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients.
Weksler BB; Pett SB; Alonso D; Richter RC; Stelzer P; Subramanian V; Tack-Goldman K; Gay WA
N Engl J Med; 1983 Apr; 308(14):800-5. PubMed ID: 6339916
[TBL] [Abstract][Full Text] [Related]
34. Long-term ultra-low-dose aspirin therapy and platelet function.
Chetty N; Atkinson PM; Bradlow BA
S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
[TBL] [Abstract][Full Text] [Related]
35. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of acetylsalicylic acid on platelet function in patients with completed stroke or reversible ischemic neurologic deficit.
Lee TK; Chen YC; Lien IN; Liu MC; Huang ZS
Stroke; 1988 May; 19(5):566-70. PubMed ID: 3363589
[TBL] [Abstract][Full Text] [Related]
37. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.
Spectre G; Arnetz L; Östenson CG; Brismar K; Li N; Hjemdahl P
Thromb Haemost; 2011 Sep; 106(3):491-9. PubMed ID: 21800009
[TBL] [Abstract][Full Text] [Related]
38. Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia.
Walsh SW
Am J Perinatol; 1989 Apr; 6(2):124-32. PubMed ID: 2653334
[TBL] [Abstract][Full Text] [Related]
39. Thromboxane biosynthesis and platelet function in type II diabetes mellitus.
Davì G; Catalano I; Averna M; Notarbartolo A; Strano A; Ciabattoni G; Patrono C
N Engl J Med; 1990 Jun; 322(25):1769-74. PubMed ID: 2345567
[TBL] [Abstract][Full Text] [Related]
40. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
